Uranium Royalty has delivered a mixed ride for shareholders over the past few years, which now puts fresh focus on whether the current price around US$3.04 is properly supported by its earnings profile. With the stock still shaped by a long 5 year drawdown, the key issue for you is how the market is weighing its profit potential today. Over the last 5 years the share price has declined 44.7%, which makes the earnings-based valuation question more about recovery expectations than recent...
In early October 2026, Uranium Royalty Corp. filed a shelf registration of about US$915.95 million for up to 226,719,982 common shares, expanding its capacity to raise capital over time. This sizeable shelf registration highlights the company’s intention to retain funding flexibility, which can influence how investors think about future equity issuance and ownership dilution. We’ll now explore how this large potential common share issuance shapes Uranium Royalty Corp.’s investment narrative...
Newswire.ca Press Release.
Zacks spotlights Oportun Financial, Uranium Royalty and Amgen, alongside standout gains from its key stock portfolios.
Uranium Royalty (UROY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
This is the newest page. Registered accounts read further back.